| TALC | TALC | 7SEV7J4R1U | GRANULE, DELAYED RELEASE / ORAL | | 525 mg | Exact identifier — unii candidate 35 equally ranked IID candidates |
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAMUSCULAR | | 150 mg | Exact identifier — unii candidate 38 equally ranked IID candidates |
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | CAPSULE, EXTENDED RELEASE / ORAL | | 1246 mg | Exact identifier — unii candidate 28 equally ranked IID candidates |
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | IMPLANT / SUBCUTANEOUS | 0.5 mg | | Exact identifier — unii candidate 39 equally ranked IID candidates |
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | CAPSULE, COATED PELLETS / ORAL | 3.32 mg | | Exact identifier — unii candidate 27 equally ranked IID candidates |
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | CAPSULE / ORAL | | 1488 mg | Exact identifier — unii candidate 27 equally ranked IID candidates |
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | TABLET, DELAYED RELEASE / ORAL | | 2313 mg | Exact identifier — unii candidate 38 equally ranked IID candidates |
| FERRIC OXIDE YELLOW | FERRIC OXIDE YELLOW | EX438O2MRT | SUSPENSION / ORAL | | 6 mg | Exact identifier — unii candidate 20 equally ranked IID candidates |
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET / SUBLINGUAL | 43.2 mg | | Exact identifier — unii candidate 28 equally ranked IID candidates |
| FERRIC OXIDE YELLOW | FERRIC OXIDE YELLOW | EX438O2MRT | TABLET, ORALLY DISINTEGRATING / ORAL | | 2 mg | Exact identifier — unii candidate 20 equally ranked IID candidates |
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | POWDER / ORAL | | 50 mg | Exact identifier — unii candidate 38 equally ranked IID candidates |
| TALC | TALC | 7SEV7J4R1U | TABLET, CHEWABLE, EXTENDED RELEASE / ORAL | | 18 mg | Exact identifier — unii candidate 35 equally ranked IID candidates |
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | POWDER, FOR SUSPENSION / ORAL | NA | | Exact identifier — unii candidate 38 equally ranked IID candidates |
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | INSERT / VAGINAL | | 8 mg | Exact identifier — unii candidate 49 equally ranked IID candidates |
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | POWDER / ORAL | | 602 mg | Exact identifier — unii candidate 49 equally ranked IID candidates |
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | PELLET / ORAL | | 1140 mg | Exact identifier — unii candidate 28 equally ranked IID candidates |
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE / ORAL | | 300 mg | Exact identifier — unii candidate 49 equally ranked IID candidates |
| TALC | TALC | 7SEV7J4R1U | GRANULE / ORAL | | 322 mg | Exact identifier — unii candidate 35 equally ranked IID candidates |
| HYDROXYPROPYL CELLULOSE (TYPE H) | HYDROXYPROPYL CELLULOSE (1600000 WAMW) | RFW2ET671P | TABLET, CHEWABLE / ORAL | | 10 mg | Exact identifier — unii candidate 27 equally ranked IID candidates |
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET, COATED / ORAL | | 58 mg | Exact identifier — unii candidate 27 equally ranked IID candidates |
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | LOTION / TOPICAL | 0.1 %w/w | | Exact identifier — unii candidate 27 equally ranked IID candidates |
| FERRIC OXIDE YELLOW | FERRIC OXIDE YELLOW | EX438O2MRT | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | | 2 mg | Exact identifier — unii candidate 20 equally ranked IID candidates |
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | | 336 mg | Exact identifier — unii candidate 49 equally ranked IID candidates |
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | CREAM / VAGINAL | | 586 mg | Exact identifier — unii candidate 38 equally ranked IID candidates |
| HYDROXYPROPYL CELLULOSE (TYPE H) | HYDROXYPROPYL CELLULOSE (1600000 WAMW) | RFW2ET671P | GEL / TRANSDERMAL | | 20 mg | Exact identifier — unii candidate 27 equally ranked IID candidates |
| HYDROXYPROPYL CELLULOSE (TYPE H) | HYDROXYPROPYL CELLULOSE (1600000 WAMW) | RFW2ET671P | FILM, EXTENDED RELEASE / TRANSDERMAL | 19 mg | | Exact identifier — unii candidate 27 equally ranked IID candidates |
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | POWDER, FOR SOLUTION / ORAL | | 690 mg | Exact identifier — unii candidate 28 equally ranked IID candidates |
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, CHEWABLE / ORAL | | 127 mg | Exact identifier — unii candidate 39 equally ranked IID candidates |
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, CHEWABLE / ORAL | | 1725 mg | Exact identifier — unii candidate 28 equally ranked IID candidates |
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | CAPSULE / ORAL | | 2169 mg | Exact identifier — unii candidate 28 equally ranked IID candidates |
| TALC | TALC | 7SEV7J4R1U | GUM, CHEWING / BUCCAL | NA | | Exact identifier — unii candidate 35 equally ranked IID candidates |
| TALC | TALC | 7SEV7J4R1U | CAPSULE, EXTENDED RELEASE / ORAL | | 5119 mg | Exact identifier — unii candidate 35 equally ranked IID candidates |
| HYDROXYPROPYL CELLULOSE (TYPE H) | HYDROXYPROPYL CELLULOSE (1600000 WAMW) | RFW2ET671P | TABLET, EXTENDED RELEASE / ORAL | | 864 mg | Exact identifier — unii candidate 27 equally ranked IID candidates |
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | LOZENGE / TRANSMUCOSAL | | 100 mg | Exact identifier — unii candidate 39 equally ranked IID candidates |
| HYDROXYPROPYL CELLULOSE (TYPE H) | HYDROXYPROPYL CELLULOSE (1600000 WAMW) | RFW2ET671P | CAPSULE / ORAL | | 120 mg | Exact identifier — unii candidate 27 equally ranked IID candidates |
| HYDROXYPROPYL CELLULOSE (TYPE H) | HYDROXYPROPYL CELLULOSE (1600000 WAMW) | RFW2ET671P | LOTION, AUGMENTED / TOPICAL | 0.2 %w/w | | Exact identifier — unii candidate 27 equally ranked IID candidates |
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | LOZENGE / ORAL | | 420 mg | Exact identifier — unii candidate 39 equally ranked IID candidates |
| HYDROXYPROPYL CELLULOSE (TYPE H) | HYDROXYPROPYL CELLULOSE (1600000 WAMW) | RFW2ET671P | TABLET, ORALLY DISINTEGRATING / ORAL | | 4 mg | Exact identifier — unii candidate 27 equally ranked IID candidates |
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | INJECTION / INTRAMUSCULAR | | 150 mg | Exact identifier — unii candidate 38 equally ranked IID candidates |
| HYDROXYPROPYL CELLULOSE (TYPE H) | HYDROXYPROPYL CELLULOSE (1600000 WAMW) | RFW2ET671P | CAPSULE, DELAYED RELEASE / ORAL | | 150 mg | Exact identifier — unii candidate 27 equally ranked IID candidates |
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | CAPSULE, DELAYED RELEASE / ORAL | | 366 mg | Exact identifier — unii candidate 28 equally ranked IID candidates |
| TALC | TALC | 7SEV7J4R1U | SUSPENSION, EXTENDED RELEASE / ORAL | | 46 mg | Exact identifier — unii candidate 35 equally ranked IID candidates |
| TALC | TALC | 7SEV7J4R1U | TABLET, DELAYED RELEASE / ORAL | | 349 mg | Exact identifier — unii candidate 35 equally ranked IID candidates |
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, ORALLY DISINTEGRATING / ORAL | | 68 mg | Exact identifier — unii candidate 49 equally ranked IID candidates |
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | GEL / NASAL | | 20 mg | Exact identifier — unii candidate 49 equally ranked IID candidates |
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | TABLET / BUCCAL | | 43 mg | Exact identifier — unii candidate 38 equally ranked IID candidates |
| FERRIC OXIDE YELLOW | FERRIC OXIDE YELLOW | EX438O2MRT | TABLET, EXTENDED RELEASE / ORAL | | 15 mg | Exact identifier — unii candidate 20 equally ranked IID candidates |
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL | NA | | Exact identifier — unii candidate 49 equally ranked IID candidates |
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 690 mg | | Exact identifier — unii candidate 38 equally ranked IID candidates |
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | TABLET, CHEWABLE / ORAL | | 1412 mg | Exact identifier — unii candidate 38 equally ranked IID candidates |
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR | | 214 mg | Exact identifier — unii candidate 38 equally ranked IID candidates |
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, FOR SUSPENSION / ORAL | | 20100 mg | Exact identifier — unii candidate 28 equally ranked IID candidates |
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 221 mg | | Exact identifier — unii candidate 27 equally ranked IID candidates |
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | POWDER, FOR SOLUTION / ORAL | | 280 mg | Exact identifier — unii candidate 49 equally ranked IID candidates |
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, DELAYED RELEASE PARTICLES / ORAL | | 580 mg | Exact identifier — unii candidate 28 equally ranked IID candidates |
| TALC | TALC | 7SEV7J4R1U | POWDER, FOR SUSPENSION / ORAL | | 735 mg | Exact identifier — unii candidate 35 equally ranked IID candidates |
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | POWDER / RESPIRATORY (INHALATION) | NA | | Exact identifier — unii candidate 49 equally ranked IID candidates |
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, CHEWABLE, EXTENDED RELEASE / ORAL | | 2 mg | Exact identifier — unii candidate 49 equally ranked IID candidates |
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | IMPLANT / INTRAVITREAL | NA | | Exact identifier — unii candidate 39 equally ranked IID candidates |
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUS | 107 mg | | Exact identifier — unii candidate 38 equally ranked IID candidates |